Amman, July 9 (Petra) – Jordan’s Ram Pharmaceutical Industries and
Saudi Arabia’s Cigalah Healthcare on Thursday launched an investment
partnership aimed at strengthening value-added investment in Jordan
and expanding Jordanian-Saudi economic cooperation.

Minister of Investment Tareq Abu Ghazaleh, who attended the launch
ceremony, said Jordanian-Saudi relations are a model of deep-rooted
ties, adding that the partnership reflects the depth of economic
relations between the two countries and confidence among
private-sector institutions.

He said the partnership marks an important step toward stronger Arab
economic integration and cooperation in one of the most strategic
sectors.

Investment in pharmaceuticals and healthcare is an investment in
people, quality of life and societies’ ability to withstand
challenges and crises, Abu Ghazaleh said, noting that an advanced
pharmaceutical industry has become a strategic necessity for health
security and national and economic resilience.

He said Jordan has built an advanced pharmaceutical manufacturing
sector over decades, with products reaching dozens of regional and
global markets.

Under the Economic Modernization Vision, the government gives special
attention to value-added industries, particularly pharmaceuticals, as
sectors capable of driving sustainable growth and creating quality
jobs, he added.

Abu Ghazaleh said the partnership reflects confidence in Jordan’s
investment environment, modern legislation, competitive advantages,
qualified workforce, advanced infrastructure and access to regional
and global markets.

He congratulated the two companies on launching the strategic
partnership, expressing hope that it would serve as a model for
further Arab investment partnerships and regional economic
integration.

Participants said the partnership would strengthen economic
cooperation between Jordan and Saudi Arabia, reflect the strength of
bilateral relations and open new prospects for Arab economic
integration.

The launch comes amid growing regional and international interest in
the pharmaceutical industry as a strategic sector that supports
health security, supply chains, knowledge and technology transfer,
exports and job creation.

The partnership builds on the strengths of two leading companies in
the pharmaceutical and healthcare sectors, both of which have a
strong presence in Arab and international markets.

//Petra// AO